Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 27
  • 1
  • 2
  • »
Discover recommendations for cancer care providers to improve care quality and outcomes for patients with acute myeloid leukemia who do not receive a transplant.
In the past, patients diagnosed with rare cancer types often faced a bleak prognosis due to limited treatment options. Today, the story is different, as advances in precision medicine and the development of new, targeted therapies continue to permeate the oncology space.
ACCC shares a look at the current NTRK testing landscape and identifies effective ways to optimize comprehensive biomarker testing in practice.
This ACCC multi-year program supported multidisciplinary providers in the care of patients with hepatocellular carcinoma.
While cancer continues to be among the leading causes of death worldwide, an increasing number of patients are surviving the disease as medical advancements in treatment, testing, and screening improve their prognoses. It is estimated that there were 16.9 million cancer survivors in the United States as of January 2019, and that number is projected to increase to 22.2 million by 2030. With June being …
By Diane Mapes For the immunocompromised and those with disease, social distancing and uncertainty are a way of life. Daily walks, gratitude, and dancing help. You’re washing your hands like crazy. Staying six feet away from people with the sniffles. You don’t know if it’s safe to hug your friends or family, or go to work, or what. You don’t even know if you’ll be alive in a year. It’s scary. …
Though the incidence of AIDS-defining cancers has decreased with the use of antiretroviral therapy, numerous studies suggest that non-AIDS-defining cancers (cancers not previously associated with HIV and AIDS) appear to be increasing in incidence.
St. Joseph Hospital and St. Jude Medical Center combined their neuro-oncology conferences and used video technology to facilitate and improve provider collaboration between institutions. The working model evaluates and addresses current needs while allowing room for additional program growth, having a positive impact on the lives of patients and increasing engagement of physicians within the local …
About half of all bladder cancers detected each year in the United States are non-invasive, while around one in three spreads to deeper cell layers in the bladder wall.
Publications Comprehensive Care of Patients with Advanced Prostate Cancer through Shared Decision-Making: Landscape Analysis. By reviewing the current state of personal engagement in decision-making for patients with advanced prostate cancer, this paper identifies obstacles to shared decision-making proposes new ways to better educate patients about their treatment options. Overcoming Prostate Cancer …
Our Partner Our Supporter Financial support provided by Pfizer Oncology.
Our Supporter Our Partner
The following websites allow you to search for multiple myeloma clinical trials. In addition, individual cancer centers and hospitals that conduct clinical trials may maintain listings of those trials on their websites. National Cancer Institute The National Cancer Institute (NCI) maintains a list of 8,000 open trials. The list includes trials supported by NCI, pharmaceutical companies, academic …
The project explored the reasons for, and develop suggestions to correct, discrepancies in the treatment journey for patients with multiple myeloma who receive ASCT as part of their therapy.
The following links provide resources to help providers educate their patients about clinical trials and find financial assistance programs. American Cancer Society This site contains factsheets, videos, worksheets, and other resources and tools for both clinicians and patients. National Cancer Institute Through the publications locator, NCI provides numerous fact sheets, …
Multiple myeloma, also known as myeloma, is the third most common hematologic cancer (cancer of the blood). However, compared to more frequently occurring cancers (e.g., breast, prostate, lung, and colorectal cancers), multiple myeloma is relative rare and accounts for only 1.6 percent of diagnoses each year. For 2018, the American Cancer Society estimates that 30,770 new cases of myeloma will be diagnosed …
The main goal of this project is to raise awareness about provider education needs related to the multiple myeloma patient population.
A number of professional organizations, advocacy groups, and healthcare institutions provide easy-to-understand, accessible, and useful information for multiple myeloma patients and their families. This list is not comprehensive but includes a core set of resources. American Cancer Society The Society is a national voluntary organization that is focused on the elimination of cancer. Specific …
The following links provide resources to help providers educate their patients bout available financial assistance programs. BenefitsCheckUp BenefitsCheckUp is a free service of the National Council on Aging (NCOA),which asks a series of questions to help identify benefits that could save patints money and cover the costs of everyday expenses. After answering the questions, patients receive …
Project Objectives To raise awareness about the special needs of caring for less common cancers in the community setting, including how to stay up-to-date on the latest clinical information and treatment protocols around renal cell carcinoma. To identify effective practices, including education materials and resources, for supporting renal cell carcinoma patients through diagnosis, …
    Displaying results 1 - 20 of 27
  • 1
  • 2
  • »